Methyl 1-(3-((tert-butoxycarbonyl)(methyl)amino)propyl)piperidine-2-carboxylate

Catalog No. :
ACDJTV235
CAS No. :
1313712-13-8
Molecular Formula :
C16H30N2O4
Molecular Weight :
314.43

IUPAC Name:methyl 1-(3-((tert-butoxycarbonyl)(methyl)amino)propyl)piperidine-2-carboxylate

Methyl 1-(3-((tert-butoxycarbonyl)(methyl)amino)propyl)piperidine-2-carboxylate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
250mg95%$449.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameMethyl 1-(3-((tert-butoxycarbonyl)(methyl)amino)propyl)piperidine-2-carboxylate
IUPAC Namemethyl 1-(3-((tert-butoxycarbonyl)(methyl)amino)propyl)piperidine-2-carboxylate
MDL No.MFCD19441857
Molecular FormulaC16H30N2O4
Molecular Weight314.43
SMILESO=C(C1N(CCCN(C(OC(C)(C)C)=O)C)CCCC1)OC
InChI KeyPCKBURMQDNEOFI-UHFFFAOYSA-N
Synonym1-[3-(tert-Butoxycarbonyl-Methyl-aMino)-propyl]-piperidine-_x000D_ 2-carboxylic acid Methyl ester;Methyl 1-(3-((tert-butoxycarbonyl)(Methyl)aMino)propyl)piperidine-2-carboxylate;2-Piperidinecarboxylic acid, 1-[3-[[(1,1-dimethylethoxy)carbonyl]methylamino]propyl]-, methyl ester
CAS No.1313712-13-8

Synthetic Route by SureRoute

1. ACDJTV235 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACQKMV327 route compound structure diagram
    ACQKMV327273757-11-2 In Stock
  2. Plus
  3. ACXGQS538 route compound structure diagram
    ACXGQS53818650-38-9 In Stock
  4. Then
  5. ACDJTV235 route product structure diagram
    ACDJTV2351313712-13-8
Inquiry

2. ACDJTV235 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACQKMV327 route compound structure diagram
    ACQKMV327273757-11-2 In Stock
  2. Plus
  3. ACSEYV743 route compound structure diagram
    ACSEYV74318650-39-0 In Stock
  4. Then
  5. ACDJTV235 route product structure diagram
    ACDJTV2351313712-13-8
Inquiry

Comments (0)